About: http://data.cimple.eu/news-article/e5ea1ade3c4c1d138a84136ba61addf09ea881696942bdfbb71f0aba     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • A German biotech firm on Monday flatly denied newspaper reports that US president Donald Trump had offered to pay for exclusive rights to a coronavirus vaccine. Citing sources close to the German government, Die Welt newspaper had reported that Trump had offered "a billion dollars" to secure research into a vaccine by CureVac "only for the United States". The report sparked a furious response in Berlin -- and a swift denial from the company. "CureVac has not received from the US government or related entities an offer before, during and since the Task Force meeting in the White House on March 2," the company tweeted. "CureVac rejects all allegations from press." German Chancellor Angela Merkel later weighed in, telling reporters the "subject is now resolved", without elaborating. She added that her government had "dealt with (the situation) very swiftly". The Die Welt report was published shortly after CureVac announced CEO Daniel Menichella had been replaced by Ingmar Hoerr, just weeks after Menichella met with Trump and representatives of drug companies in Washington. Scientists are scrambling to find a vaccine for the new coronavirus, which first emerged in China in December but has since ballooned across Asia, Europe and North America. Cases in Africa and Latin America are mounting as well. The virus has already infected more than 175,00 and killed over 7,000 globally, according to an AFP tally. On Monday, the US National Institutes of Health opened the first human trial to evaluate a candidate vaccine against the virus, but it could take up to 18 months before it becomes available. CureVac also said on its website: "Internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide." kih/hmn/jv/jxb
schema:headline
  • German biotech firm denies Trump vaccine offer
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software